CompoAtlas

MentaPlex

Natural health product licensed in Canada

Licence holder
Natural Equivalents Incorporated
NPN or DIN-HM
80032590
Status
Inactive licence
Licence date
4 June 2012
Revision date
Not provided
Form
Liquide
Application type
Homéopathique

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Lycopodium clavatum

Source : Spore(s)

6 X
Hyoscyamus niger

Source : Plante entière fleurissante

6 X
Baryta carbonica

Source : Carbonate de baryum

10 X
Anacardium occidentale

Source : Jus provenant de la couche entre la cosse et le noyau du fruit

6 X
Lathyrus sativus

Source : Graine(s)

4 X
Soufre natif

Source : Soufre sublimé

10 X
Gelsemium sempervirens

Source : Racine

6 X
Magnesia phosphorica

Source : Phosphate de magnésium, dibasique

10 X
Phosphoricum acidum

Source : Acide phosphorique

10 X
Aconitum napellus

Source : Plante(s) entière

6 X
Conium maculatum

Source : Sommité(s) en fleurs

6 X
Aesculus hippocastanum

Source : Noix mûr y compris la coquille externe

4 X
Picricum acidum

Source : Acide picrique

10 X
Arnica montana

Source : Plante entière y compris la racine

28 X
Selenium metallicum

Source : Sélénium gris

10 X

Non-medicinal ingredients

Éthanol, Eau

PopulationAgeQuantity per servingFrequency
AdultesNot specified10 Goutte(s)3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Homeopathic medicine used to temporarily relieve weak concentration, mental weakness, restlessness, nervousness, and impaired memory.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80032590

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line